粉样-β 病理增加了猫类认知功能障碍综合征中细胞质的突触吞:阿尔茨海默氏病的自然发生模型
Robert I McGeachan1,2,3, Lucy Ewbank1,2, Meg Watt4
1Centre for Discovery Brain Sciences, The University of Edinburgh, Edinburgh, UK.
The European journal of neuroscience
|August 12, 2025
概括
猫类认知功能障碍综合征 (CDS) 与人类有类似阿尔茨海默氏症的脑部变化. 老年和CDS受影响的猫的突触和质细胞参与中氨基酸β积累反映了人类阿尔茨海默病的病理学.
科学领域:
- 神经科学是一个神经科学.
- 比较病理学比较病理学
- 兽医神经学 兽医神经学
背景情况:
- 猫类认知功能障碍综合征 (CDS) 或猫类痴呆症是猫的与年龄相关的神经退行性疾病.
- 它呈现出类似于人类痴呆症的行为变化.
- 老猫的脑缩和粉样β斑等病理类似于人类阿尔茨海默病 (AD) 的病理.
研究的目的:
- 研究神经炎症和突触损失在猫类认知功能障碍综合征中的作用.
- 探索涉及猫大脑中粉样β和质细胞的突触损失机制.
- 评估猫类CDS作为人类阿尔茨海默病的翻译模型.
主要方法:
- 免疫组织化学和共聚焦显微镜被用于分析年轻,老年和患有CDS的猫头皮质组织.
- 应用了线性混合效应建模来量化病理变化.
- 研究了粉样蛋白-β,微质症,星质症和突触结构的特定标志物.
主要成果:
- 发现粉样蛋白-β在老年和受CDS影响的猫的突触内积聚.
- 在粉样β斑块附近观察到增加的微质,星质,以及微质和星球细胞的突触吞.
- 微质细胞和星体细胞显示,含粉样β突触的内部化增加.
结论:
- 在突触中粉样β的积累和相关的神经炎症有助于猫的认知功能障碍.
- 猫类CDS的病理机制与人类阿尔茨海默氏症中观察到的病理机制非常相似.
- 猫类CDS作为一种有价值的自然发生的模型,用于研究阿尔茨海默病的发病因子和开发治疗策略.
相关概念视频
Amyloid Fibrils
9.9K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.9K
Alzheimer's Disease: Overview
668
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
668


